Vioxx Withdrawal Fuels Criticism Of DTC; Liability Exposure May Be Test
Executive Summary
The Vioxx withdrawal will prompt renewed debate over DTC advertising
You may also be interested in...
WLF Questions Ad Division Allegations; “DDMAC Watch” Starts With Strattera
Direct-to-consumer advertising does not endanger the public health because access to prescription drugs is controlled by physicians, not the public, the Washington Legal Foundation's new advertising regulation watchdog group suggests
WLF Questions Ad Division Allegations; “DDMAC Watch” Starts With Strattera
Direct-to-consumer advertising does not endanger the public health because access to prescription drugs is controlled by physicians, not the public, the Washington Legal Foundation's new advertising regulation watchdog group suggests
Vioxx Cardiovascular Risk Is Unique To Molecule, Pfizer And Novartis Tell FDA
The cardiovascular safety signal observed in Merck's Vioxx may be caused by the formation of potentially toxic rofecoxib metabolites, Pfizer states in its briefing documents for FDA's upcoming review of COX-2 inhibitors